Sponsor or institution
Clinical trials and research at Amplo Biotechnology, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $5.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeted ColQ gene therapy for a congenital nerve-muscle disorder
A new gene therapy approach aims to help children and adults with a rare congenital muscle weakness called ColQ CMS by delivering a corrected gene using an AAV-based system.
-
Gene therapy targeting the ColQ gene for treating congenital myasthenic syndromes.
This study is testing a new gene therapy to help people with Congenital Myasthenic Syndromes caused by problems with a protein called Collagen Q, aiming to improve muscle strength and make daily life easier for those affected.
-
Gene therapy targeting the DOK7 gene for treating congenital myasthenic syndromes.
This study is testing a new gene therapy for people with Congenital Myasthenic Syndromes caused by changes in the DOK7 gene, aiming to improve muscle strength and quality of life by fixing the genetic issue that affects how muscles work.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.